{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:12:30Z","timestamp":1790975550399,"version":"4.1.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adult growth hormone (GH) deficiency is associated with increased body fat mass, abdominal obesity, dyslipidaemia, reduced exercise capacity, impaired cardiac function, reduced self-reported well-being, impaired quality of life, as well as increased morbidity. Randomised controlled trials and cohort studies, together with meta-analyses, have shown improved outcome in adult patients with hypopituitarism receiving GH, with a reassuring safety profile. Women with GH deficiency and hypopituitarism have greater morbidity and mortality than men, particularly in relation to metabolic and cardiovascular outcome. The response to GH replacement is also less favourable in women than in men. The reason for these differences in women and men with hypopituitarism is not entirely clear, but is likely related to the interaction between sex steroid and the somatotroph axis. In this narrative review we summarize the burden of GH deficiency in adults with hypopituitarism, and the impact of GH replacement, with focus on differences among women and men.<\/jats:p>","DOI":"10.1007\/s11102-026-01646-0","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T13:38:52Z","timestamp":1771594732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular and metabolic outcomes of GH replacement therapy in adults with GH deficiency \u2013 gender gaps"],"prefix":"10.1007","volume":"29","author":[{"given":"Angelo","family":"Milioto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"26","key":"1646_CR1","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1056\/NEJMra1817346","volume":"380","author":"S Melmed","year":"2019","unstructured":"Melmed S (2019) Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med 380(26):2551\u20132562. https:\/\/doi.org\/10.1056\/NEJMra1817346","journal-title":"N Engl J Med"},{"key":"1646_CR2","doi-asserted-by":"crossref","unstructured":"Esposito D, Johannsson G, Ragnarsson O (2021) Chapter 9 - Endocrinological diagnosis and replacement therapy for hypopituitarism. In: Honegger J, Reincke M, Petersenn S (eds) Pituitary tumors. Academic, pp 135\u2013146","DOI":"10.1016\/B978-0-12-819949-7.00027-5"},{"issue":"5","key":"1646_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s11102-017-0811-0","volume":"20","author":"D Esposito","year":"2017","unstructured":"Esposito D, Trimpou P, Giugliano D, Dehlin M, Ragnarsson O (2017) Pituitary dysfunction in granulomatosis with polyangiitis. Pituitary 20(5):594\u2013601. https:\/\/doi.org\/10.1007\/s11102-017-0811-0","journal-title":"Pituitary"},{"issue":"2","key":"1646_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1210\/er.2008-0027","volume":"30","author":"N Moller","year":"2009","unstructured":"Moller N, Jorgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152\u2013177. https:\/\/doi.org\/10.1210\/er.2008-0027","journal-title":"Endocr Rev"},{"issue":"5","key":"1646_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1530\/EJE-12-1083","volume":"168","author":"M Elbornsson","year":"2013","unstructured":"Elbornsson M, Gotherstrom G, Bosaeus I, Bengtsson BA, Johannsson G, Svensson J (2013) Fifteen years of GH replacement improves body composition and cardiovascular risk factors. Eur J Endocrinol 168(5):745\u2013753. https:\/\/doi.org\/10.1530\/EJE-12-1083","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1646_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jcem.82.2.3776","volume":"82","author":"P Burman","year":"1997","unstructured":"Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA (1997) Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82(2):550\u2013555. https:\/\/doi.org\/10.1210\/jcem.82.2.3776","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1646_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/edrv.19.6.0353","volume":"19","author":"A Giustina","year":"1998","unstructured":"Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19(6):717\u2013797. https:\/\/doi.org\/10.1210\/edrv.19.6.0353","journal-title":"Endocr Rev"},{"issue":"1","key":"1646_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1210\/jcem-64-1-51","volume":"64","author":"KY Ho","year":"1987","unstructured":"Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E et al (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64(1):51\u20138. https:\/\/doi.org\/10.1210\/jcem-64-1-51","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1646_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1210\/jcem.78.3.8126124","volume":"78","author":"A Weltman","year":"1994","unstructured":"Weltman A, Weltman JY, Hartman ML, Abbott RD, Rogol AD, Evans WS et al (1994) Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. J Clin Endocrinol Metab 78(3):543\u20138. https:\/\/doi.org\/10.1210\/jcem.78.3.8126124","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1646_CR10","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1210\/jcem.83.5.4761","volume":"83","author":"P Ovesen","year":"1998","unstructured":"Ovesen P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, Jorgensen JO (1998) Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. J Clin Endocrinol Metab 83(5):1662\u20131667. https:\/\/doi.org\/10.1210\/jcem.83.5.4761","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1646_CR11","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1210\/jc.2013-3059","volume":"99","author":"M Bidlingmaier","year":"2014","unstructured":"Bidlingmaier M, Friedrich N, Emeny RT, Spranger J, Wolthers OD, Roswall J et al (2014) Reference intervals for insulin-like growth factor-1 (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J Clin Endocrinol Metab 99(5):1712\u201321. https:\/\/doi.org\/10.1210\/jc.2013-3059","journal-title":"J Clin Endocrinol Metab"},{"issue":"6 Pt 1","key":"1646_CR12","doi-asserted-by":"publisher","first-page":"E1108","DOI":"10.1152\/ajpendo.1997.272.6.E1108","volume":"272","author":"N Vahl","year":"1997","unstructured":"Vahl N, Jorgensen JO, Skjaerbaek C, Veldhuis JD, Orskov H, Christiansen JS (1997) Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am J Physiol 272(6 Pt 1):E1108\u2013E1116. https:\/\/doi.org\/10.1152\/ajpendo.1997.272.6.E1108","journal-title":"Am J Physiol"},{"issue":"6","key":"1646_CR13","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/joim.13382","volume":"290","author":"G Johannsson","year":"2021","unstructured":"Johannsson G, Ragnarsson O (2021) Growth hormone deficiency in adults with hypopituitarism-what are the risks and can they be eliminated by therapy? J Intern Med 290(6):1180\u20131193. https:\/\/doi.org\/10.1111\/joim.13382","journal-title":"J Intern Med"},{"issue":"5","key":"1646_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693\u2013721. https:\/\/doi.org\/10.1210\/er.2003-0035","journal-title":"Endocr Rev"},{"issue":"1","key":"1646_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1677\/joe.0.1470147","volume":"147","author":"S Yang","year":"1995","unstructured":"Yang S, Xu X, Bjorntorp P, Eden S (1995) Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats. J Endocrinol 147(1):147\u2013152. https:\/\/doi.org\/10.1677\/joe.0.1470147","journal-title":"J Endocrinol"},{"issue":"6","key":"1646_CR16","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1210\/endo.133.6.8243263","volume":"133","author":"DF Carmignac","year":"1993","unstructured":"Carmignac DF, Gabrielsson BG, Robinson IC (1993) Growth hormone binding protein in the rat: effects of gonadal steroids. Endocrinology 133(6):2445\u20132452. https:\/\/doi.org\/10.1210\/endo.133.6.8243263","journal-title":"Endocrinology"},{"issue":"3","key":"1646_CR17","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1073\/pnas.0337600100","volume":"100","author":"KC Leung","year":"2003","unstructured":"Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH et al (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci U S A 100(3):1016\u201321. https:\/\/doi.org\/10.1073\/pnas.0337600100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1646_CR18","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine S (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(6):1587\u2013609. https:\/\/doi.org\/10.1210\/jc.2011-0179","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1646_CR19","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"KK Ho","year":"2007","unstructured":"Ho KK, Participants GHDCW (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157(6):695\u2013700. https:\/\/doi.org\/10.1530\/EJE-07-0631","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1646_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","volume":"25","author":"KCJ Yuen","year":"2019","unstructured":"Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM et al (2019) American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract 25(11):1191\u2013232. https:\/\/doi.org\/10.4158\/GL-2019-0405","journal-title":"Endocr Pract"},{"issue":"3","key":"1646_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1210\/jc.2004-1450","volume":"90","author":"XD Qu","year":"2005","unstructured":"Qu XD, Gaw Gonzalo IT, Al Sayed MY, Cohan P, Christenson PD, Swerdloff RS et al (2005) Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests. J Clin Endocrinol Metab 90(3):1563\u20139. https:\/\/doi.org\/10.1210\/jc.2004-1450","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1646_CR22","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1210\/jc.2018-00665","volume":"103","author":"JM Garcia","year":"2018","unstructured":"Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ et al (2018) Macimorelin as a diagnostic test for adult GH deficiency. J Clin Endocrinol Metab 103(8):3083\u201393. https:\/\/doi.org\/10.1210\/jc.2018-00665","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1646_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1530\/EC-20-0491","volume":"10","author":"JM Garcia","year":"2021","unstructured":"Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ et al (2021) Sensitivity and specificity of the macimorelin test for diagnosis of AGHD. Endocr Connect 10(1):76\u201383. https:\/\/doi.org\/10.1530\/EC-20-0491","journal-title":"Endocr Connect"},{"issue":"9","key":"1646_CR24","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1210\/jc.2005-0597","volume":"90","author":"A Colao","year":"2005","unstructured":"Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S et al (2005) Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency. J Clin Endocrinol Metab 90(9):5146\u201355. https:\/\/doi.org\/10.1210\/jc.2005-0597","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1646_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.eprac.2021.06.003","volume":"27","author":"SJ Kang","year":"2021","unstructured":"Kang SJ, Kwon A, Jung MK, Chae HW, Kim S, Koh H et al (2021) High prevalence of nonalcoholic fatty liver disease among adolescents and young adults with hypopituitarism due to growth hormone deficiency. Endocr Pract 27(11):1149\u201355. https:\/\/doi.org\/10.1016\/j.eprac.2021.06.003","journal-title":"Endocr Pract"},{"issue":"3","key":"1646_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11154-024-09873-1","volume":"25","author":"D Esposito","year":"2024","unstructured":"Esposito D, Tivesten A, Olivius C, Ragnarsson O, Johannsson G (2024) Androgen deficiency in hypopituitary women: its consequences and management. Rev Endocr Metab Disord 25(3):479\u201388. https:\/\/doi.org\/10.1007\/s11154-024-09873-1","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"1646_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1046\/j.1365-2265.1998.00424.x","volume":"48","author":"JOL J\u00f8rgensen","year":"1998","unstructured":"J\u00f8rgensen JOL, Vahl N, Hansen TB, Skj\u00e6rb\u00e6k C, Fisker S, \u00d8rskov H et al (1998) Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects. Clin Endocrinol 48(4):479\u201386. https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00424.x","journal-title":"Clin Endocrinol"},{"issue":"6","key":"1646_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1530\/eje.0.1410601","volume":"141","author":"S Fisker","year":"1999","unstructured":"Fisker S, Jorgensen JO, Vahl N, Orskov H, Christiansen JS (1999) Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults. Eur J Endocrinol 141(6):601\u2013608. https:\/\/doi.org\/10.1530\/eje.0.1410601","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"1646_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000080762","volume":"62","author":"JO Jorgensen","year":"2004","unstructured":"Jorgensen JO, Christensen JJ, Krag M, Fisker S, Ovesen P, Christiansen JS (2004) Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids. Horm Res 62(Suppl 1):73\u201376. https:\/\/doi.org\/10.1159\/000080762","journal-title":"Horm Res"},{"issue":"2","key":"1646_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1210\/jcem-72-2-374","volume":"72","author":"AJ Weissberger","year":"1991","unstructured":"Weissberger AJ, Ho KK, Lazarus L (1991) Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72(2):374\u2013381. https:\/\/doi.org\/10.1210\/jcem-72-2-374","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1646_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1365-2265.1993.tb02410.x","volume":"39","author":"JJ Kelly","year":"1993","unstructured":"Kelly JJ, Rajkovic IA, O\u2019Sullivan AJ, Sernia C, Ho KK (1993) Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf) 39(5):561\u2013567. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb02410.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1646_CR32","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1210\/jcem.81.4.8636370","volume":"81","author":"G Johannsson","year":"1996","unstructured":"Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P et al (1996) The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab 81(4):1575\u201381. https:\/\/doi.org\/10.1210\/jcem.81.4.8636370","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1646_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1530\/EJE-09-0973","volume":"162","author":"EJ Barbosa","year":"2010","unstructured":"Barbosa EJ, Koranyi J, Filipsson H, Bengtsson BA, Boguszewski CL, Johannsson G (2010) Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults. Eur J Endocrinol 162(5):869\u2013878. https:\/\/doi.org\/10.1530\/EJE-09-0973","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1646_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1210\/jcem.82.1.3643","volume":"82","author":"AF Attanasio","year":"1997","unstructured":"Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK et al (1997) Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82(1):82\u20138. https:\/\/doi.org\/10.1210\/jcem.82.1.3643","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1646_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/eje.1.02179","volume":"155","author":"R Abs","year":"2006","unstructured":"Abs R, Feldt-Rasmussen U, Mattsson AF, Monson JP, Bengtsson BA, Goth MI et al (2006) Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis. Eur J Endocrinol 155(1):79\u201390. https:\/\/doi.org\/10.1530\/eje.1.02179","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1646_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2265.1995.tb01860.x","volume":"42","author":"SA Beshyah","year":"1995","unstructured":"Beshyah SA, Freemantle C, Thomas E, Rutherford O, Page B, Murphy M et al (1995) Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 42(2):179\u2013189. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb01860.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1646_CR37","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1210\/jc.2003-030761","volume":"89","author":"RD Murray","year":"2004","unstructured":"Murray RD, Adams JE, Shalet SM (2004) Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 89(4):1586\u20131591. https:\/\/doi.org\/10.1210\/jc.2003-030761","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1646_CR38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1210\/jcem.75.3.1517374","volume":"75","author":"H De Boer","year":"1992","unstructured":"De Boer H, Blok GJ, Voerman HJ, De Vries PM, van der Veen EA (1992) Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab 75(3):833\u20137. https:\/\/doi.org\/10.1210\/jcem.75.3.1517374","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1646_CR39","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1210\/jcem.83.12.5297","volume":"83","author":"DM Hoffman","year":"1998","unstructured":"Hoffman DM, Pallasser R, Duncan M, Nguyen TV, Ho KK (1998) How is whole body protein turnover perturbed in growth hormone-deficient adults? J Clin Endocrinol Metab 83(12):4344\u20134349. https:\/\/doi.org\/10.1210\/jcem.83.12.5297","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1646_CR40","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/cen.13958","volume":"90","author":"X Zheng","year":"2019","unstructured":"Zheng X, Cheng Q, Long J, Wang Y, Gong L, Wei Q et al (2019) <article-title update=\"added\">Prevalence of low lean mass in patients with adult growth hormone deficiency with or without low\u2010dose growth hormone therapy. Clin Endocrinol 90(6):834\u201341. https:\/\/doi.org\/10.1111\/cen.13958","journal-title":"Clin Endocrinol"},{"issue":"2","key":"1646_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ghir.2008.07.001","volume":"19","author":"C Franco","year":"2009","unstructured":"Franco C, Koranyi J, Brandberg J, Lonn L, Bengtsson BK, Svensson J et al (2009) The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women. Growth Horm IGF Res 19(2):112\u2013120. https:\/\/doi.org\/10.1016\/j.ghir.2008.07.001","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"1646_CR42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s12020-021-02835-6","volume":"74","author":"A Rossini","year":"2021","unstructured":"Rossini A, Lanzi R, Galeone C, Pelucchi C, Pennacchioni M, Perticone F et al (2021) Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy. Endocrine 74(3):666\u201375. https:\/\/doi.org\/10.1007\/s12020-021-02835-6","journal-title":"Endocrine"},{"issue":"6","key":"1646_CR43","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1210\/jcem.87.6.8542","volume":"87","author":"S Ezzat","year":"2002","unstructured":"Ezzat S, Fear S, Gaillard RC, Gayle C, Landy H, Marcovitz S et al (2002) Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults. J Clin Endocrinol Metab 87(6):2725\u201333. https:\/\/doi.org\/10.1210\/jcem.87.6.8542","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1646_CR44","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2265.2001.01320.x","volume":"55","author":"TA Abdu","year":"2001","unstructured":"Abdu TA, Neary R, Elhadd TA, Akber M, Clayton RN (2001) Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin Endocrinol (Oxf) 55(2):209\u2013216. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01320.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"1646_CR45","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1210\/jcem.81.7.8675559","volume":"81","author":"D O'Neal","year":"1996","unstructured":"O\u2019Neal D, Hew FL, Sikaris K, Ward G, Alford F, Best JD (1996) Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy. J Clin Endocrinol Metab 81(7):2448\u201354. https:\/\/doi.org\/10.1210\/jcem.81.7.8675559","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1646_CR46","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ejendo\/lvae060","volume":"190","author":"TNA Slagboom","year":"2024","unstructured":"Slagboom TNA, van der Lely AJ, Drent ML, van Bunderen CC (2024) Exploring the sex difference in cardiovascular risk during growth hormone therapy in adults. Eur J Endocrinol 190(6):434\u201345. https:\/\/doi.org\/10.1093\/ejendo\/lvae060","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"1646_CR47","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","volume":"89","author":"M Rudling","year":"1992","unstructured":"Rudling M, Norstedt G, Olivecrona H, Reihner E, Gustafsson JA, Angelin B (1992) Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci U S A 89(15):6983\u20136987. https:\/\/doi.org\/10.1073\/pnas.89.15.6983","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1646_CR48","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1210\/endo.131.6.1446613","volume":"131","author":"MB Elam","year":"1992","unstructured":"Elam MB, Wilcox HG, Solomon SS, Heimberg M (1992) In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver. Endocrinology 131(6):2717\u20132722. https:\/\/doi.org\/10.1210\/endo.131.6.1446613","journal-title":"Endocrinology"},{"issue":"6","key":"1646_CR49","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0022-2275(20)32034-4","volume":"41","author":"JA Beentjes","year":"2000","unstructured":"Beentjes JA, van Tol A, Sluiter WJ, Dullaart RP (2000) Effect of growth hormone replacement therapy on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities in growth hormone-deficient adults. J Lipid Res 41(6):925\u201332","journal-title":"J Lipid Res"},{"issue":"1","key":"1646_CR50","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/EJE-12-0252","volume":"167","author":"H Nishizawa","year":"2012","unstructured":"Nishizawa H, Iguchi G, Murawaki A, Fukuoka H, Hayashi Y, Kaji H et al (2012) Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. Eur J Endocrinol 167(1):67\u201374. https:\/\/doi.org\/10.1530\/EJE-12-0252","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1646_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1507\/endocrj.EJ23-0157","volume":"70","author":"T Kong","year":"2023","unstructured":"Kong T, Gu Y, Sun L, Zhou R, Li J, Shi J (2023) Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis. Endocr J 70(10):959\u2013967. https:\/\/doi.org\/10.1507\/endocrj.EJ23-0157","journal-title":"Endocr J"},{"issue":"5","key":"1646_CR52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ghir.2014.07.002","volume":"24","author":"R Matsumoto","year":"2014","unstructured":"Matsumoto R, Fukuoka H, Iguchi G, Nishizawa H, Bando H, Suda K et al (2014) Long-term effects of growth hormone replacement therapy on liver function in adult patients with growth hormone deficiency. Growth Horm IGF Res 24(5):174\u20139. https:\/\/doi.org\/10.1016\/j.ghir.2014.07.002","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"1646_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/EJE-12-0807","volume":"168","author":"R Abs","year":"2013","unstructured":"Abs R, Mattsson AF, Thunander M, Verhelst J, Goth MI, Wilton P et al (2013) Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur J Endocrinol 168(3):297\u2013305. https:\/\/doi.org\/10.1530\/EJE-12-0807","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1646_CR54","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1210\/clinem\/dgac199","volume":"107","author":"G Johannsson","year":"2022","unstructured":"Johannsson G, Touraine P, Feldt-Rasmussen U, Pico A, Vila G, Mattsson AF et al (2022) Long-term safety of growth hormone in adults with growth hormone deficiency: overview of 15 809 GH-treated patients. J Clin Endocrinol Metab 107(7):1906\u201319. https:\/\/doi.org\/10.1210\/clinem\/dgac199","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1646_CR55","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1210\/jc.2011-0448","volume":"96","author":"AF Attanasio","year":"2011","unstructured":"Attanasio AF, Jung H, Mo D, Chanson P, Bouillon R, Ho KK et al (2011) Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis. J Clin Endocrinol Metab 96(7):2255\u201361. https:\/\/doi.org\/10.1210\/jc.2011-0448","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1646_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2337\/dc11-0449","volume":"35","author":"A Luger","year":"2012","unstructured":"Luger A, Mattsson AF, Koltowska-Haggstrom M, Thunander M, Goth M, Verhelst J et al (2012) Incidence of diabetes mellitus and evolution of glucose parameters in growth hormone-deficient subjects during growth hormone replacement therapy: a long-term observational study. Diabetes Care 35(1):57\u201362. https:\/\/doi.org\/10.2337\/dc11-0449","journal-title":"Diabetes Care"},{"issue":"1","key":"1646_CR57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/EJE-16-0173","volume":"175","author":"DS Olsson","year":"2016","unstructured":"Olsson DS, Bryngelsson IL, Ragnarsson O (2016) Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study. Eur J Endocrinol 175(1):55\u201361. https:\/\/doi.org\/10.1530\/EJE-16-0173","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1646_CR58","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-2265.2002.01514.x","volume":"56","author":"JC Smith","year":"2002","unstructured":"Smith JC, Evans LM, Wilkinson I, Goodfellow J, Cockcroft JR, Scanlon MF et al (2002) Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf) 56(4):493\u2013501. https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01514.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1646_CR59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1530\/eje.0.1410481","volume":"141","author":"A Sanmarti","year":"1999","unstructured":"Sanmarti A, Lucas A, Hawkins F, Webb SM, Ulied A (1999) Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Eur J Endocrinol 141(5):481\u20139. https:\/\/doi.org\/10.1530\/eje.0.1410481","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1646_CR60","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1365-2265.2004.02105.x","volume":"61","author":"A Colao","year":"2004","unstructured":"Colao A, Di Somma C, Filippella M, Rota F, Pivonello R, Orio F et al (2004) Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 61(3):360\u20136. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02105.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1646_CR61","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1210\/jcem.77.6.8263155","volume":"77","author":"B Merola","year":"1993","unstructured":"Merola B, Cittadini A, Colao A, Longobardi S, Fazio S, Sabatini D et al (1993) Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. J Clin Endocrinol Metab 77(6):1658\u201361. https:\/\/doi.org\/10.1210\/jcem.77.6.8263155","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1646_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/hrt.67.1.92","volume":"67","author":"M Shahi","year":"1992","unstructured":"Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA (1992) Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 67(1):92\u201396. https:\/\/doi.org\/10.1136\/hrt.67.1.92","journal-title":"Br Heart J"},{"key":"1646_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.910575","volume":"13","author":"F Bioletto","year":"2022","unstructured":"Bioletto F, Prencipe N, Berton AM, Bona C, Parasiliti-Caprino M, Faletti R et al (2022) MRI assessment of cardiac function and morphology in adult patients with growth hormone deficiency: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 13:910575. https:\/\/doi.org\/10.3389\/fendo.2022.910575","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1646_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-010-0250-7","volume":"14","author":"M Andreassen","year":"2011","unstructured":"Andreassen M, Faber J, Kjaer A, Petersen CL, Kristensen LO (2011) Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study. Pituitary 14(1):1\u201310. https:\/\/doi.org\/10.1007\/s11102-010-0250-7","journal-title":"Pituitary"},{"issue":"3","key":"1646_CR65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s12020-016-1067-6","volume":"54","author":"JD Thomas","year":"2016","unstructured":"Thomas JD, Dattani A, Zemrak F, Burchell T, Akker SA, Gurnell M et al (2016) Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance. Endocrine 54(3):778\u201387. https:\/\/doi.org\/10.1007\/s12020-016-1067-6","journal-title":"Endocrine"},{"issue":"5","key":"1646_CR66","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2265.1994.tb01827.x","volume":"41","author":"L Thuesen","year":"1994","unstructured":"Thuesen L, Jorgensen JO, Muller JR, Kristensen BO, Skakkebaek NE, Vahl N et al (1994) Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults. Clin Endocrinol (Oxf) 41(5):615\u2013620. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb01827.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1646_CR67","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1210\/jcem.80.2.7852533","volume":"80","author":"R Valcavi","year":"1995","unstructured":"Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I (1995) Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 80(2):659\u2013666. https:\/\/doi.org\/10.1210\/jcem.80.2.7852533","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1646_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11102-022-01207-1","volume":"25","author":"B Ratku","year":"2022","unstructured":"Ratku B, Sebestyen V, Erdei A, Nagy EV, Szabo Z, Somodi S (2022) Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile. Pituitary 25(2):211\u2013228. https:\/\/doi.org\/10.1007\/s11102-022-01207-1","journal-title":"Pituitary"},{"issue":"3","key":"1646_CR69","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2265.1994.tb03937.x","volume":"40","author":"K Caidahl","year":"1994","unstructured":"Caidahl K, Eden S, Bengtsson BA (1994) Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf) 40(3):393\u2013400. https:\/\/doi.org\/10.1111\/j.1365-2265.1994.tb03937.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1646_CR70","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1210\/jc.2003-030840","volume":"89","author":"P Maison","year":"2004","unstructured":"Maison P, Griffin S, Nicoue-Beglah M, Haddad N, Balkau B, Chanson P (2004) Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 89(5):2192\u20139. https:\/\/doi.org\/10.1210\/jc.2003-030840","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1646_CR71","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1530\/EJE-09-0266","volume":"161","author":"M Koltowska-Haggstrom","year":"2009","unstructured":"Koltowska-Haggstrom M, Mattsson AF, Shalet SM (2009) Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol 161(1):S51-64. https:\/\/doi.org\/10.1530\/EJE-09-0266","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1646_CR72","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1210\/jcem.84.11.6088","volume":"84","author":"BA Bengtsson","year":"1999","unstructured":"Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E et al (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS study group and the KIMS international board. J Clin Endocrinol Metab 84(11):3929\u20133935. https:\/\/doi.org\/10.1210\/jcem.84.11.6088","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1646_CR73","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab002","volume":"5","author":"ML Monzani","year":"2021","unstructured":"Monzani ML, Pederzoli S, Volpi L, Magnani E, Diazzi C, Rochira V (2021) Sexual dysfunction: a neglected and overlooked issue in adult GH deficiency: the management of AGHD study. J Endocr Soc 5(3):bvab002. https:\/\/doi.org\/10.1210\/jendso\/bvab002","journal-title":"J Endocr Soc"},{"issue":"12","key":"1646_CR74","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1210\/jc.2014-2892","volume":"99","author":"D Mo","year":"2014","unstructured":"Mo D, Blum WF, Rosilio M, Webb SM, Qi R, Strasburger CJ (2014) Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study. J Clin Endocrinol Metab 99(12):4581\u20134588. https:\/\/doi.org\/10.1210\/jc.2014-2892","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1646_CR75","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11154-020-09599-w","volume":"22","author":"CC van Bunderen","year":"2021","unstructured":"van Bunderen CC, Olsson DS (2021) Growth hormone deficiency and replacement therapy in adults: impact on survival. Rev Endocr Metab Disord 22(1):125\u201333. https:\/\/doi.org\/10.1007\/s11154-020-09599-w","journal-title":"Rev Endocr Metab Disord"},{"issue":"9254","key":"1646_CR76","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s0140-6736(00)04006-x","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS et al (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425\u201331. https:\/\/doi.org\/10.1016\/s0140-6736(00)04006-x","journal-title":"Lancet"},{"issue":"10","key":"1646_CR77","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1210\/jc.2011-1215","volume":"96","author":"CC van Bunderen","year":"2011","unstructured":"van Bunderen CC, van Nieuwpoort IC, Arwert LI, Heymans MW, Franken AA, Koppeschaar HP et al (2011) Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National registry of growth hormone treatment in adults. J Clin Endocrinol Metab 96(10):3151\u20133159. https:\/\/doi.org\/10.1210\/jc.2011-1215","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1646_CR78","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1210\/jc.2012-2684","volume":"98","author":"ML Hartman","year":"2013","unstructured":"Hartman ML, Xu R, Crowe BJ, Robison LL, Erfurth EM, Kleinberg DL et al (2013) Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients. J Clin Endocrinol Metab 98(3):980\u20138. https:\/\/doi.org\/10.1210\/jc.2012-2684","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1646_CR79","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1210\/jc.2014-3787","volume":"100","author":"JM Pappachan","year":"2015","unstructured":"Pappachan JM, Raskauskiene D, Kutty VR, Clayton RN (2015) Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. J Clin Endocrinol Metab 100(4):1405\u20131411. https:\/\/doi.org\/10.1210\/jc.2014-3787","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1646_CR80","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/EJE-16-0450","volume":"176","author":"DS Olsson","year":"2017","unstructured":"Olsson DS, Trimpou P, Hallen T, Bryngelsson IL, Andersson E, Skoglund T et al (2017) Life expectancy in patients with pituitary adenoma receiving growth hormone replacement. Eur J Endocrinol 176(1):67\u201375. https:\/\/doi.org\/10.1530\/EJE-16-0450","journal-title":"Eur J Endocrinol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01646-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01646-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01646-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:34:03Z","timestamp":1781634843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01646-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1646"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01646-0","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.M. and OR declares no relevant conflicts of interest. D.E. has received lecture fees from Ipsen, Recordati, and Pfizer AB. G.J. has served as a consultant for Novo Nordisk and Crinetics; and has received lecture fees from Ascendis Pharma, Crinetics, Pharmanovia and Novo Nordisk.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}